Breast cancer is the most frequently diagnosed cancer type and the second leading cause of cancer-related deaths among women worldwide. The causes of breast cancer are not yet fully known, although a number of risk factors have been identified. Tumor biomarker is a term used to describe potential markers of cancer development and progression. As we explore these biomarkers further, we must try to understand the underlying mechanisms of tumor development, as we move along the path to discovery of novel therapies that will increase our ability to offer personalized patient care in the future. With the migration of advanced high throughput technologies, such as Next Generation Sequencing from clinical practice, biomarker research and discovery are poised to explode once again. Translation of novel biomarkers into clinical practice and diagnostic laboratories is coupled with regulatory and administrative requirements that must be met, while collaboration between research institutions, industry, and the private sector drives further advancements in the field of breast cancer biomarker discovery and application.
The aim of this special issue is to provide new findings regarding molecular pathways and biomarkers that could improve the diagnosis and the prognostic classification of breast cancers, their application in the clinical setting, and their potential utility in personalized patient therapy. The total of submissions is 50. After single-blind peer review by at least two reviewers, 14 papers were finally accepted to be published. The accepted rate is 28%. The average number of authors for each accepted paper is 7. The affiliated institutes of the authors are from Brazil, China, Italy, Iraq, Jordan, Portugal, Spain, Saudi Arabia, Taiwan, the UK, and the USA. These accepted papers can be organized in different groups. The focus of the first group of articles is on prognosis and therapy in breast cancer. The findings of the paper titled "Exploring the Role of Breast Density on Cancer Prognosis among Women Attending Population-Based Screening Programmes" by Domingo et al. reveal that increased breast density was associated with worse survival outcomes among women participating in breast cancer screening. The paper titled "Attenuated Total Reflection-Fourier Transform Infrared (ATR-FTIR) Spectroscopy Analysis of Saliva for In summary, the research papers cover a wide range of applications including potential diagnostics, predictions, and treatment. Furthermore, this special issue also includes regional genetic mutation, breast density on cancer prognosis, small RNA as a biomarker, surface marker of cancer stem cells, potential marker of cancer metastasis, and spectroscopy predicting the rate of cancer. This may be helpful in assessing prognostic or predictive indicators, as well as developing new therapies and new insights aimed at improving breast cancer.
